Q&A With Emmanuelle Waubant of UCSF: Neuroprotection and Its Role in Multiple Sclerosis Treatment

A lot of attention in the field of multiple sclerosis is being dedicated to neuroprotection and remyelination. Whether these can someday lead to more effective treatments remains to be seen but there is optimism among doctors and researchers alike.

Emmanuelle Waubant, MD, from the University of California at San Francisco discussed what she called one of the "holy grails," of multiple sclerosis treatment during the American Academy of Neurology's annual meeting in Washington DC.